Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
Carla Schettino,1,2,* Clemente Dato,1,2,* Guglielmo Capaldo,1,2 Simone Sampaolo,1,2 Giuseppe Di Iorio,1,2 Mariarosa AB Melone1,2 1Department of Medical, Surgical, Neurological, Metabolic Sciences, and Aging, 2Division of Neurology and InterUniversity Center for Research in Neurosciences, Second Uni...
Guardado en:
Autores principales: | Schettino C, Dato C, Capaldo G, Sampaolo S, Di Iorio G, Melone MA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/574e2ce14c0d4f4c9912da15c436a3a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of rasagiline in the treatment of Parkinson’s disease
por: Julie Leegwater-Kim, et al.
Publicado: (2010) -
EFFECT OF GAMMA-IRRADIATION ON BIODEGRADABLE MICROSPHERES LOADED WITH RASAGILINE MESYLATE
por: FERNÁNDEZ,MARCOS, et al.
Publicado: (2016) -
Sleep apnea leading to Parkinson’s disease – an important association
por: Shafqat MN, et al.
Publicado: (2017) -
Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease
por: Zhong M, et al.
Publicado: (2021) -
FREQUENCY AND CORRELATES OF POOR SLEEP QUALITY AMONG PATIENTS OF PARKINSON’S DISEASE
por: Syed Sakhawat Kazmi, et al.
Publicado: (2020)